Conduit Pharmaceuticals I...

NASDAQ: CDT · Real-Time Price · USD
0.48
-0.02 (-4.46%)
At close: May 06, 2025, 3:59 PM
0.51
6.65%
Pre-market: May 07, 2025, 05:38 AM EDT
-4.46%
Bid 0.48
Market Cap 5.42M
Revenue (ttm) 2.13B
Net Income (ttm) 37.69M
EPS (ttm) -20.53
PE Ratio (ttm) -0.02
Forward PE n/a
Analyst n/a
Ask 0.55
Volume 395,060
Avg. Volume (20D) 5,768,233
Open 0.50
Previous Close 0.50
Day's Range 0.47 - 0.50
52-Week Range 0.46 - 350.00
Beta 2.37

About CDT

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California...

Industry Biotechnology
Sector Healthcare
IPO Date Mar 28, 2022
Employees 6
Stock Exchange NASDAQ
Ticker Symbol CDT
Full Company Profile
3 weeks ago
-12.97%
Conduit Pharmaceuticals shares are trading lower. ... Unlock content with Pro Subscription
2 months ago
+83.87%
Conduit Pharmaceuticals shares are trading higher after the company announced it completed all milestones in Phase I of its strategic collaboration with Sarborg Limited.